Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersPeter Horak, Klaus Schulze‐Osthoff, Arne Jahn et al.|Cancer Discovery|2021Cited by 282
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologyIrina Kerle, Hanno Glimm, Thomas Groß et al.|npj Precision Oncology|2025Cited by 17
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Rainer Hamacher, Christoph E. Heilig et al.|Journal of Nuclear Medicine|2025Cited by 10
Abstract 1028: A tumor-agnostic YAP/TAZ score predicts TEAD inhibitor sensitivity independent of Hippo alterationsMichael Wegert-Verhoeven, Sebastian M. Dieter, Mathea Fransisca et al.|Cancer Research|2026Cited by 0